Scientists from Queen Mary, University of London have identified tiny organelles called primary cilia as a target for anti-inflammation therapy. “Although primary cilia were discovered more than a century ago, we’re only beginning to realize the importance they play in different diseases and conditions, and the potential therapeutic benefits that could be developed from manipulating cilia structure and function,” Martin Knight, who led the research, said. To investigate the ...
↧